UNITE is designed—a universal cfDNA feature ensemble framework that provides scalable cancer detection methods based on “genomic bin–fragment length” matrices derived from shallow whole-genome sequencing (sWGS) data at 0.1× depth.
Abstract
Cell-free DNA (cfDNA) in body fluids enables noninvasive cancer detection. Multifeature artificial intelligence (AI) can improve sensitivity by integrating diverse biomarkers when cancer signals are sparse. Tumor-informed assays that rely on mutations have limited practicality for early cancer detection. Emerging fragmentomic and epigenetic features underpin tumor-naive approaches to screening for individuals with low tumor burden. Here, we designed UNITE—a universal cfDNA feature ensemble framework that provides scalable cancer detection methods based on “genomic bin–fragment length” matrices derived from shallow whole-genome sequencing (sWGS) data at 0.1× depth. Using sWGS data from 2063 plasma samples (631 controls and 1432 cases from 26 cancer types), we systematically evaluated both XGBoost (UNITE-XGB) and convolutional neural networks (UNITE-CNN) across multiple feature spaces and cancer stages. In stage I-II cancer, UNITE-XGB and UNITE-CNN achieved 31 and 21% sensitivity, respectively, at 95% specificity. These findings provide roadmaps for developing multifeature AI beyond plasma biopsies.
Motivation: Cell-free DNA methylation provides a minimally invasive signal for early cancer detection and tissue-of-origin prediction. Most methods represent methylation measurements as independent fixed-window features and therefore do not explicitly model relationships among genomic regions. Results: We developed PAN...
L. Zhao, Y. Zeng, D. Abelman et al.· medRxiv· 0 citations
DNAmBERT, a Transformer-based deep learning framework designed to jointly model DNA sequence context and read-level methylation haplotype structure from cfDNA methylation sequencing data, indicates that integrated sequence–haplotype representation learning provides an accurate and scalable approach for cfDNA-based mult...
Maryam Yassi, Mark Ezegbogu, E. Rodger et al.· Briefings in Bioinformatics· 0 citations
Fragmentia-AI™ WGS, a mutation-calling-independent framework that uses a transformer-based multiple-instance learning architecture with sequential fine-tuning across tumor fraction (TF) strata to extract latent cancer-associated signals from ULP-WGS data, enables robust cancer detection and clinically meaningful risk s...
Yang Xu, Song Wang, Guo-Feng Sun et al.· Molecular Biomedicine· 0 citations
This stacked ensemble machine learning classifier that integrates 11 multidimensional cfDNA features spanning genomic, fragmentomic, methylation/repeat, and microbial signals provides a robust and non-invasive approach for accurate cancer type identification and has the potential to support clinical decision-making.
Yunjian Zhang, Liang Liu, H. Bao et al.· Molecular Biomedicine· 0 citations
This work developed and clinically validated the System for Enhanced Evaluation of Tumor Cells (SEE-TC), a deep learning approach for scalable, reproducible phenotyping of individual circulating cells that is the first fully automated AI approach to single-cell segmentation and CTC phenotyping.
M. Bootsma, M. Sharifi, J. Sperger et al.· Clinical Cancer Research· 0 citations
The proposed UMPM-Net is a comprehensive, explainable and robust multimodal learning framework that is capable of accurate, interpretable, and clinically relevant prognostication for colorectal cancer.
K. Muthuchamy, S. K. Piramu Preethika· Journal of Computer Science· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.